Comparison of Adverse Event Risks in Randomized Controlled Trials with Varying Follow-Up Times and Competing Events: Results from an Empirical Study

References

• Allignol, A., Beyersmann, J., and Schmoor, C. (2016), “Statistical Issues in the Analysis of Adverse Events in Time-to-Event Data,” Pharmaceutical Statistics, 15, 297–305. DOI: 10.1002/pst.1739.
   PubMed Web of Science ®Google Scholar
• Austin, P. C., and Fine, J. P. (2017), “Accounting for Competing Risks in Randomized Controlled Trials: A Review and Recommendations for Improvement,” Statistics in Medicine, 36, 1203–1209. DOI: 10.1002/sim.7215.
   PubMed Web of Science ®Google Scholar
• Budin-Ljosne, I., Burton, P., Isaeva, J., Gaye, A., Turner, A., Murtagh, M. J., Wallace, S., Ferretti, V., and Harris, J. R. (2015), “DataSHIELD: An Ethically Robust Solution to Multiple-Site Individual-Level Data Analysis,” Public Health Genomics, 18, 87–96. DOI: 10.1159/000368959.
   PubMed Web of Science ®Google Scholar
• Clark, T. G., Altman, D. G., and De Stavola, B. L. (2002), “Quantification of the Completeness of Follow-Up,” The Lancet, 359, 1309–1310. DOI: 10.1016/S0140-6736(02)08272-7.
   PubMed Web of Science ®Google Scholar
• Gooley, T. A., Leisenring, W., Crowley, J., and Storer, B. E. (1999), “Estimation of Failure Probabilities in the Presence of Competing Risks: New Representations of Old Estimators,” Statistics in Medicine, 18, 695–706. DOI: 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O.
   PubMed Web of Science ®Google Scholar
• IQWiG (2017), General Methods, Version 5.0. Institute of Quality and Efficiency in Health Care. Available at https://www.iqwig.de/en/methods/methods-paper.3020.html
   Google Scholar
• Kalbfleisch, J. D., and Prentice, R. L. (2002), The Statistical Analysis of Failure Time Data, Hoboken, NJ: Wiley.
   Google Scholar
• Koller, M. T., Raatz, H., Steyerberg, E. W., and Wolbers, M. (2012), “Competing Risks and the Clinical Community: Irrelevance or Ignorance?” Statistics in Medicine, 31, 1089–1097. DOI: 10.1002/sim.4384.
   PubMed Web of Science ®Google Scholar
• Latouche, A., Allignol, A., Beyersmann, J., Labopin, M., and Fine, J. P. (2013), “A Competing Risks Analysis should Report Results on all Cause-Specific Hazards and Cumulative Incidence Functions,” Journal of Clinical Epidemiology, 66, 648–653. DOI: 10.1016/j.jclinepi.2012.09.017.
   PubMed Web of Science ®Google Scholar
• Phillips, R., and Cornelius, V. (2020), “Understanding Current Practice, Identifying Barriers and Exploring Priorities for Adverse Event Analysis in Randomised Controlled Trials: An Online, Cross-Sectional Survey of Statisticians from Academia and Industry,” BMJ Open, 10, e036875. DOI: 10.1136/bmjopen-2020-036875.
   PubMed Web of Science ®Google Scholar
• Pocock, S. J., Clayton, T. C., and Altman, D. G. (2002), “Survival Plots of Time-to-Event Outcomes in Clinical Trials: Good Practice and Pitfalls,” The Lancet, 359, 1686–1689. DOI: 10.1016/S0140-6736(02)08594-X.
   PubMed Web of Science ®Google Scholar
• Proctor, T., and Schumacher, M. (2016), “Analysing Adverse Events by Time-to-Event Models: The Cleopatra Study,” Pharmaceutical Statistics, 15, 306–314. DOI: 10.1002/pst.1758.
   PubMed Web of Science ®Google Scholar
• Schemper, M., and Smith, T. L. (1996), “A Note on Quantifying Follow-Up in Studies of Failure Time,” Controlled Clinical Trials, 17, 343–346. DOI: 10.1016/0197-2456(96)00075-x.
   PubMedGoogle Scholar
• Schumacher, M., Ohneberg, K., and Beyersmann, J. (2016), “Competing Risk Bias was Common in a Prominent Medical Journal,” Journal of Clinical Epidemiology, 80, 135–136. DOI: 10.1016/j.jclinepi.2016.07.013.
   PubMed Web of Science ®Google Scholar
• Schuster, N. A., Hoogendijk, E. O., Kok, A. A. L., Twisk, J. W. R., and Heymans, M. W. (2020), “Ignoring Competing Events in the Analysis of Survival Data May Lead to Biased Results: A Nonmathematical Illustration of Competing Risk Analysis,” Journal of Clinical Epidemiology, 122, 42–48. DOI: 10.1016/j.jclinepi.2020.03.004.
   PubMed Web of Science ®Google Scholar
• Stegherr, R., Beyersmann, J., Jehl, V., Rufibach, K., Leverkus, F., Schmoor, C., and Friede, T. (2021a), “Survival Analysis for Adverse Events with Varying Follow-Up Times (savvy): Rationale and Statistical Concept of a Meta-Analytic Study,” Biometrical Journal, 63, 650–670. DOI: 10.1002/bimj.201900347.
   PubMed Web of Science ®Google Scholar
• Stegherr, R., Schmoor, C., Beyersmann, J., Rufibach, K., Jehl, V., Brückner, A., Eisele, L., Künzel, T., Kupas, K., Langer, F., Leverkus, F., Loos, A., Norenberg, C., Voss, F., and Friede, T. (2021b), “Survival Analysis for AdVerse Events with VarYing Follow-Up Times (SAVVY) – Estimation of Adverse Event Risks,” Trials, 22. DOI: 10.1186/s13063-021-05354-x.
   PubMed Web of Science ®Google Scholar
• Stegherr, R., Schmoor, C., Lübbert, M., Friede, T. and Beyersmann, J., (2021c), “Estimating and Comparing Adverse Event Probabilities in the Presence of Varying Follow-Up Times and Competing Events,” Pharmaceutical Statistics, 20, 1125–1146. DOI: 10.1002/pst.2130.
   PubMed Web of Science ®Google Scholar
• Therneau, T., and Grambsch, P. (2000), Modeling Survival Data: Extending the Cox Model, New York: Springer.
   Google Scholar
• Unkel, S., Amiri, M., Benda, N., Beyersmann, J., Knoerzer, D., Kupas, K., Langer, F., Leverkus, F., Loos, A., Ose, C., Proctor, T., Schmoor, C., Schwenke, C., Skipka, G., Unnebrink, K., Voss, F., and Friede, T. (2019), “On Estimands and the Analysis of Adverse Events in the Presence of Varying Follow-Up Times within the Benefit Assessment of Therapies,” Pharmaceutical Statistics, 18, 166–183. DOI: 10.1002/pst.1915.
   PubMed Web of Science ®Google Scholar
• Varadhan, R., Weiss, C. O., Segal, J. B., Wu, A. W., Scharfstein, D., and Boyd, C. (2010), “Evaluating Health Outcomes in the Presence of Competing Risks: A Review of Statistical Methods and Clinical Applications,” Medical Care, 8, S96–S105. DOI: 10.1097/MLR.0b013e3181d99107.
   Google Scholar
• Young, J. G., Stensrud, M. J., Tchetgen Tchetgen, E. J., and Hernán, M. A. (2020), “A Causal Framework for Classical Statistical Estimands in Failure-Time Settings with Competing Events,” Statistics in Medicine, 39, 1199–1236. DOI: 10.1002/sim.8471.
   PubMed Web of Science ®Google Scholar